These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33293522)

  • 41. Functional assays for analysis of variants of uncertain significance in BRCA2.
    Guidugli L; Carreira A; Caputo SM; Ehlen A; Galli A; Monteiro AN; Neuhausen SL; Hansen TV; Couch FJ; Vreeswijk MP;
    Hum Mutat; 2014 Feb; 35(2):151-64. PubMed ID: 24323938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in classification of genetic variants in BRCA1 and BRCA2.
    Kast K; Wimberger P; Arnold N
    Arch Gynecol Obstet; 2018 Feb; 297(2):279-280. PubMed ID: 29302806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
    Kwong A; Ho CYS; Shin VY; Au CH; Chan TL; Ma ESK
    BMC Med Genomics; 2022 May; 15(1):122. PubMed ID: 35641994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
    Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
    Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants.
    Park KS; Cho EY; Nam SJ; Ki CS; Kim JW
    Genet Med; 2016 Dec; 18(12):1250-1257. PubMed ID: 27124784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight
    Caleca L; Radice P
    Front Oncol; 2023; 13():1146604. PubMed ID: 37168384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes.
    Théry JC; Krieger S; Gaildrat P; Révillion F; Buisine MP; Killian A; Duponchel C; Rousselin A; Vaur D; Peyrat JP; Berthet P; Frébourg T; Martins A; Hardouin A; Tosi M
    Eur J Hum Genet; 2011 Oct; 19(10):1052-8. PubMed ID: 21673748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
    Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
    Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.
    Caleca L; Catucci I; Figlioli G; De Cecco L; Pesaran T; Ward M; Volorio S; Falanga A; Marchetti M; Iascone M; Tondini C; Zambelli A; Azzollini J; Manoukian S; Radice P; Peterlongo P
    Front Oncol; 2018; 8():480. PubMed ID: 30410870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort.
    Li H; LaDuca H; Pesaran T; Chao EC; Dolinsky JS; Parsons M; Spurdle AB; Polley EC; Shimelis H; Hart SN; Hu C; Couch FJ; Goldgar DE
    Genet Med; 2020 Apr; 22(4):701-708. PubMed ID: 31853058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Population-Based Analysis of
    Park KS; Lee W; Seong MW; Kong SY; Lee KA; Ha JS; Cho EH; Han SH; Park I; Kim JW
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34063308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay.
    Kuznetsov SG; Chang S; Sharan SK
    Methods Mol Biol; 2010; 653():259-80. PubMed ID: 20721749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
    Lindor NM; Goldgar DE; Tavtigian SV; Plon SE; Couch FJ
    Oncologist; 2013; 18(5):518-24. PubMed ID: 23615697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.
    Chang S; Biswas K; Martin BK; Stauffer S; Sharan SK
    J Clin Invest; 2009 Oct; 119(10):3160-71. PubMed ID: 19770520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants.
    Bellè F; Mercatanti A; Lodovichi S; Congregati C; Guglielmi C; Tancredi M; Caligo MA; Cervelli T; Galli A
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409408
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Khandakji M; Habish HHA; Abdulla NBS; Kusasi SAA; Abdou NMG; Al-Mulla HMMA; Al Sulaiman RJAA; Bu Jassoum SM; Mifsud B
    Physiol Genomics; 2023 Aug; 55(8):315-323. PubMed ID: 37335020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer.
    Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW
    BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance.
    Richardson ME; Hu C; Lee KY; LaDuca H; Fulk K; Durda KM; Deckman AM; Goldgar DE; Monteiro ANA; Gnanaolivu R; Hart SN; Polley EC; Chao E; Pesaran T; Couch FJ
    Am J Hum Genet; 2021 Mar; 108(3):458-468. PubMed ID: 33609447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reclassification of Five BRCA1/2 Variants with Unknown Significance Using Complex Functional Study.
    Bozsik A; Papp J; Grolmusz VK; Patócs A; Oláh E; Butz H
    Cancer Res Treat; 2022 Oct; 54(4):970-984. PubMed ID: 35167739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.